Stratos Wealth Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.11M Buy
19,690
+13,011
+195% +$1.4M 0.03% 476
2025
Q1
$674K Sell
6,679
-16,911
-72% -$1.71M 0.01% 789
2024
Q4
$2.11M Buy
23,590
+13,597
+136% +$1.21M 0.03% 461
2024
Q3
$837K Sell
9,993
-23,053
-70% -$1.93M 0.01% 752
2024
Q2
$2.54M Buy
33,046
+3,470
+12% +$267K 0.04% 389
2024
Q1
$2.03M Buy
29,576
+18,348
+163% +$1.26M 0.03% 435
2023
Q4
$649K Buy
11,228
+2,611
+30% +$151K 0.01% 773
2023
Q3
$455K Buy
8,617
+182
+2% +$9.61K 0.01% 852
2023
Q2
$456K Sell
8,435
-2,376
-22% -$129K 0.01% 800
2023
Q1
$541K Buy
10,811
+964
+10% +$48.2K 0.01% 672
2022
Q4
$456K Buy
9,847
+675
+7% +$31.2K 0.01% 761
2022
Q3
$355K Sell
9,172
-425
-4% -$16.5K 0.01% 801
2022
Q2
$358K Buy
9,597
+817
+9% +$30.5K 0.01% 856
2022
Q1
$389K Sell
8,780
-82
-0.9% -$3.63K 0.01% 903
2021
Q4
$376K Buy
8,862
+200
+2% +$8.49K 0.01% 921
2021
Q3
$376K Buy
8,662
+249
+3% +$10.8K 0.01% 867
2021
Q2
$360K Buy
8,413
+401
+5% +$17.2K 0.01% 900
2021
Q1
$310K Buy
8,012
+1,739
+28% +$67.3K 0.01% 871
2020
Q4
$226K Sell
6,273
-470
-7% -$16.9K 0.01% 959
2020
Q3
$258K Buy
6,743
+274
+4% +$10.5K 0.01% 839
2020
Q2
$227K Sell
6,469
-506
-7% -$17.8K 0.01% 858
2020
Q1
$228K Buy
6,975
+351
+5% +$11.5K 0.01% 769
2019
Q4
$300K Buy
6,624
+1,076
+19% +$48.7K 0.01% 756
2019
Q3
$226K Buy
5,548
+617
+13% +$25.1K 0.01% 837
2019
Q2
$212K Buy
+4,931
New +$212K 0.01% 858
2018
Q4
Sell
-3,088
Closed -$119K 1016
2018
Q3
$119K Buy
+3,088
New +$119K 0.01% 1045
2018
Q2
Sell
-1,790
Closed -$49K 1165
2018
Q1
$49K Sell
1,790
-1,291
-42% -$35.3K ﹤0.01% 1583
2017
Q4
$76K Buy
+3,081
New +$76K ﹤0.01% 1311